Catalytic domain of the human effector cell cycle checkpoint...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/54 (2006.01) C12N 5/10 (2006.01) C12N 9/12 (2006.01) C12N 15/70 (2006.01) C12Q 1/34 (2006.01) C12Q 1/48 (2006.01)

Patent

CA 2325228

The present invention relates to the identification, isolation and purification of the catalytic domain of the human effector checkpoint protein kinase (hChkl). A 1.7.OMICRON. crystal structure of the hChkl kinase domain in the active conformation is reported herein. The kinase domain of hChkl and its associated crystal structure is described for use in the discovery, identification and characterization of inhibitors of hChkl. This structure provides a three- dimensional description of the binding site of the hChkl for structure-based design of small molecule inhibitors thereof as therapeutic agents. Inhibitors of hChkl find utility in the treatment of hyperproliferative disorders such as HIV and cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Catalytic domain of the human effector cell cycle checkpoint... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Catalytic domain of the human effector cell cycle checkpoint..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catalytic domain of the human effector cell cycle checkpoint... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1406109

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.